Clinical Trial Update: CYP3A4 Metabolism Before and After Surgery Induced Weight Loss Using Midazolam as Model Drug [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating how weight loss surgery affects CYP3A4 metabolism using midazolam as a model drug in morbid obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Obesity-related Conditions

Drugs mentioned

• Midazolam (Midazolam)

Snippet

Sponsor: St. Antonius Hospital | Conditions: Morbid Obesity | Phase 4 | Status: COMPLETED